Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.

Milani P, Rajkumar SV, Merlini G, Kumar S, Gertz MA, Palladini G, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Kapoor P, Go RS, Hwa YL, Gonsalves WI, Zeldenrust SR, Kyle RA, Dispenzieri A.

Am J Hematol. 2016 Aug 10. doi: 10.1002/ajh.24532. [Epub ahead of print]

PMID:
27508522
2.

Outcomes of patients with renal monoclonal immunoglobulin deposition disease.

Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N.

Am J Hematol. 2016 Aug 8. doi: 10.1002/ajh.24528. [Epub ahead of print]

PMID:
27501122
3.

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type.

Muchtar E, Dispenzieri A, Kumar SK, Dingli D, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Leung N, Chakraborty R, Russel S, Lust JA, Lin Y, Go RS, Zeldenrust S, Kyle RA, Rajkumar SV, Gertz MA.

Haematologica. 2016 Jun 16. pii: haematol.2016.147041. [Epub ahead of print]

4.

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma.

Ravi P, Kumar S, Larsen JT, Gonsalves W, Buadi F, Lacy MQ, Go R, Dispenzieri A, Kapoor P, Lust JA, Dingli D, Lin Y, Russell SJ, Leung N, Gertz MA, Kyle RA, Bergsagel PL, Rajkumar SV.

Blood Cancer J. 2016 Jul 29;6(7):e454. doi: 10.1038/bcj.2016.65.

PMID:
27471870
5.

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.

Hwa YL, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Kourelis TV, Gonsalves WI, Rajkumar SV, Go RS, Leung N, Kapoor P, Dingli D, Kyle RA, Russell S, Lust JA, Hayman SR, Lin Y, Zeldenrust S, Dispenzieri A.

Am J Hematol. 2016 Jun 24. doi: 10.1002/ajh.24453. [Epub ahead of print]

PMID:
27341539
6.

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.

Higgins LS, Go RS, Dingli D, Kumar SK, Rajkumar SV, Dispenzieri A, Buadi FK, Lacy MQ, Lust JA, Kapoor P, Leung N, Lin Y, Kourelis TV, Gertz MA, Kyle RA, Gonsalves WI.

Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):447-52. doi: 10.1016/j.clml.2016.04.009. Epub 2016 May 5.

PMID:
27238425
7.

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival.

Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Kourelis TV, Gonsalves W, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Kyle RA, Rajkumar SV, Gertz MA.

Leukemia. 2016 Jun 10. doi: 10.1038/leu.2016.140. [Epub ahead of print]

PMID:
27211265
8.

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.

Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D, Go RS, Kapoor P, Lust JA, Hayman SR, Hwa Y, Rajkumar SV, Zeldenrust SR, Russell SJ, Lin Y, Leung N, Kyle RA, Gonsalves WI, Dispenzieri A.

Am J Hematol. 2016 Jun;91(6):585-9. doi: 10.1002/ajh.24356. Epub 2016 Apr 13.

PMID:
26972803
9.

Clinical characteristics and outcomes in biclonal gammopathies.

Mullikin TC, Rajkumar SV, Dispenzieri A, Buadi FK, Lacy MQ, Lin Y, Dingli D, Go RS, Hayman SR, Zeldenrust SR, Russell SJ, Lust JA, Leung N, Kapoor P, Kyle RA, Gertz MA, Kumar SK.

Am J Hematol. 2016 May;91(5):473-5. doi: 10.1002/ajh.24319. Epub 2016 Apr 6.

PMID:
26840395
10.

Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.

Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Hwa YL, Gonsalves W, Kyle RA, Dispenzieri A.

Leukemia. 2016 May;30(5):1079-85. doi: 10.1038/leu.2015.344. Epub 2015 Dec 16.

PMID:
26669974
11.

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.

Leung N, Kumar SK, Glavey SV, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Kapoor P, Zeldenrust SR, Russell SJ, Lust JA, Hogan WJ, Rajkumar SV, Gastineau DA, Kourelis TV, Lin Y, Gonsalves WI, Go RS, Gertz MA.

Nephrol Dial Transplant. 2016 Aug;31(8):1284-9. doi: 10.1093/ndt/gfv328. Epub 2015 Nov 30.

PMID:
26627634
12.

IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.

Xiu B, Lin Y, Grote DM, Ziesmer SC, Gustafson MP, Maas ML, Zhang Z, Dietz AB, Porrata LF, Novak AJ, Liang AB, Yang ZZ, Ansell SM.

Blood Cancer J. 2015 Jul 31;5:e328. doi: 10.1038/bcj.2015.56.

13.

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency.

Cordes S, Gertz MA, Buadi FK, Lin Y, Lacy MQ, Kapoor P, Kumar SK, McCurdy A, Dispenzieri A, Dingli D, Hayman SR, Hogan WJ, Pruthi RK.

Blood Coagul Fibrinolysis. 2016 Jan;27(1):101-8. doi: 10.1097/MBC.0000000000000367.

PMID:
26218969
14.

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma.

Binder M, Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Buadi FK, Dingli D, Hayman SR, Lust JA, Kapoor P, Lin Y, Go RS, Hwa YL, Kyle RA, Kumar SK.

Am J Hematol. 2015 Oct;90(10):888-91. doi: 10.1002/ajh.24107. Epub 2015 Sep 1.

PMID:
26148022
15.

Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance.

Zhang ZJ, Bulur PA, Dogan A, Gastineau DA, Dietz AB, Lin Y.

Oncoimmunology. 2015 Jan 26;4(4):e996470. eCollection 2015 Apr.

16.

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.

Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, Bulur PA, Harrington SM, Laborde RR, Gastineau DA, Leibovich BC, Cheville JC, Kwon ED, Dietz AB.

Clin Cancer Res. 2015 Sep 15;21(18):4224-33. doi: 10.1158/1078-0432.CCR-15-0260. Epub 2015 May 21.

PMID:
25999436
17.

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death.

Warsame R, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Ketterling RP, Lin Y, Russell S, Hwa L, Kapoor P, Go RS, Zeldenrust SR, Kyle RA, Rajkumar SV, Dispenzieri A.

Blood Cancer J. 2015 May 1;5:e310. doi: 10.1038/bcj.2015.34.

18.

A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans.

Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, Gastineau DA, Dietz AB.

PLoS One. 2015 Mar 23;10(3):e0121546. doi: 10.1371/journal.pone.0121546. eCollection 2015.

19.

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.

Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Kapoor P, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust S, Kyle RA, Gertz MA, Kumar SK.

Blood Cancer J. 2015 Mar 20;5:e296. doi: 10.1038/bcj.2015.20.

20.

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis.

Kaufman GP, Dispenzieri A, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Kapoor P, Go RS, Zeldenrust SR, Kyle RA, Rajkumar SV, Kumar SK.

Am J Hematol. 2015 Mar;90(3):181-6. doi: 10.1002/ajh.23898. Epub 2015 Jan 16.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk